Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 22,081 | 19,571 | 27,885 | 3,767 | 0 |
| Gross Profit | 22,081 | 19,571 | 27,885 | 3,767 | 0 |
| Operating Expenses | 48,581 | 40,301 | 26,684 | 13,783 | 8,817 |
| Operating Income | -26,500 | -20,730 | 1,201 | -10,016 | -8,817 |
| Interest Expense | 481 | 439 | 493 | 453 | 403 |
| Other Income | 5,453 | 3,574 | 1,409 | 1,983 | 4,077 |
| Pre-tax Income | -21,528 | -17,595 | 2,117 | -8,486 | -5,143 |
| Income Tax | 0 | 0 | 80 | 0 | 0 |
| Net Income Continuous | -21,528 | -17,595 | 2,037 | -8,486 | -5,143 |
| Net Income | $-21,528 | $-17,595 | $2,037 | $-8,486 | $-5,143 |
| EPS Basic Total Ops | -0.63 | -0.56 | 0.08 | -0.36 | -0.39 |
| EPS Basic Continuous Ops | -0.62 | -0.56 | 0.08 | -0.35 | -0.22 |
| EPS Diluted Total Ops | -0.63 | -0.56 | 0.08 | -0.35 | -0.22 |
| EPS Diluted Continuous Ops | -0.62 | -0.56 | 0.08 | -0.35 | -0.22 |
| EBITDA(a) | $-22,790 | $-17,245 | $5,099 | $-7,242 | $-6,989 |